aifinyo AG

Companies

aifinyo AG is Germany's first pure-play Bitcoin treasury company, announced in October 2025. Founded in 2012 and publicly listed since 2018, the company operates two BaFin-regulated subsidiaries — aifinyo finance GmbH (factoring and leasing) and aifinyo payments GmbH (payment institution) — serving 8,000 business customers through its Smart Billment invoice management platform. The company has adopted a MicroStrategy-style strategy, with UTXO Management as a strategic investor, targeting accumulation of 10,000 BTC by 2027.

Details

Ceo: Stefan Kempf
Sector: fintech_factoring
Ticker: EBEN
Country: Germany
Notable: Germany's first Bitcoin treasury company (Oct 2025); backed by UTXO Management; operates BaFin-supervised subsidiaries
Exchange: Frankfurt
Industry: Fintech / Bitcoin Treasury
Founded Year: 2018
Headquarters: Berlin, Germany
Bitcoin Target: 10,000 BTC by 2027
Exchange Listed: Frankfurt Stock Exchange / Xetra
Bitcoin Holdings: 35
Bitcoin Strategy: Bitcoin treasury company. German fintech that added Bitcoin to its corporate balance sheet as a treasury reserve asset.
Btc Holdings Date: 2025-10
Bitcoin Holdings Date: 2025-06

Links

twitter

More Companies

Strategy (formerly MicroStrategy)

Strategy (Nasdaq: MSTR), formerly MicroStrategy, is the world's largest corporate Bitcoin holder. Founded by Michael Saylor, the company rebranded in 2025 to reflect its identity as a Bitcoin treasury company. It holds over 500,000 BTC accumulated through equity and debt financing, pioneering the corporate Bitcoin standard that inspired hundreds of companies worldwide.

ACINQ

ACINQ is a French Bitcoin infrastructure company and the developer of Eclair, one of the three major Lightning Network implementations. Founded in 2014, ACINQ builds Phoenix Wallet (a non-custodial Lightning wallet) and operates the ACINQ Lightning node, one of the most well-connected nodes on the Lightning Network.

Acurx Pharmaceuticals

Acurx Pharmaceuticals (NASDAQ: ACXP) is a US biopharmaceutical company that made headlines in November 2021 by adopting Bitcoin as its primary treasury reserve asset — one of the first pharmaceutical companies to do so. The company approved purchasing $1 million in Bitcoin and has continued to hold BTC alongside its drug development pipeline focused on antibiotics. Notable for crossing industry boundaries to embrace the Bitcoin standard.